Utah Medical Products Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| 14.4 | 13.3 | 11.2 | 8.9 | 8.3 | 11.9 | 14.0 | 6.1 | 10.3 | 17.8 | 16.3 | 15.0 | 11.8 | 17.0 | 16.3 | 13.3 | 13.2 | 18.9 | 19.9 | 18.6 | 22.6 | 35.8 | 16.8 | 27.4 | 28.7 | 24.7 | 22.2 | 18.4 | 15.5 | 16.1 | |
| 3.3 | 2.4 | 2.0 | 1.7 | 1.6 | 2.6 | 3.7 | 4.7 | 4.0 | 4.8 | 4.6 | 4.2 | 3.1 | 4.1 | 3.9 | 2.6 | 3.2 | 5.3 | 5.5 | 5.5 | 7.0 | 7.3 | 7.4 | 8.6 | 7.3 | 7.5 | 7.0 | 6.1 | 5.3 | 4.7 | |
| 5.2 | 2.5 | 2.1 | 2.6 | 3.6 | 3.9 | 6.4 | 3.5 | 2.9 | 4.1 | 3.7 | 3.1 | 2.5 | 2.8 | 2.6 | 2.4 | 2.6 | 3.6 | 3.5 | 3.2 | 4.0 | 3.9 | 3.5 | 4.0 | 3.0 | 3.4 | 3.2 | 2.4 | 1.8 | 1.5 | |
| – | – | – | – | 2.0 | 2.7 | 3.8 | – | – | 5.0 | 4.8 | 4.3 | 3.1 | 4.2 | 3.8 | 3.0 | 3.4 | 5.2 | 5.1 | 4.9 | 6.3 | 6.4 | – | 7.7 | 6.1 | 6.2 | 5.6 | 4.2 | 3.2 | – | |
| – | – | – | – | 5.1 | 6.5 | 9.0 | – | – | 14.0 | 12.0 | 10.7 | 7.5 | 10.5 | 9.9 | 7.8 | 7.6 | 11.7 | 10.8 | 10.5 | 13.0 | 12.1 | – | 14.7 | 12.3 | 11.6 | 10.5 | 8.6 | 6.8 | – | |
| 23.9 | 15.1 | 11.4 | 5.8 | 6.0 | 9.6 | 12.4 | 16.1 | 3.9 | 22.0 | 12.7 | 16.7 | 11.4 | 15.8 | 17.4 | 8.9 | 10.1 | 18.0 | 15.9 | 16.3 | 24.4 | 19.9 | 19.0 | – | 16.1 | 17.7 | 18.0 | 14.2 | 14.8 | 12.7 | |
| 4.2% | 6.6% | 8.8% | 17.2% | 16.7% | 10.4% | 8.1% | 6.2% | 25.8% | 4.6% | 7.9% | 6.0% | 8.8% | 6.3% | 5.7% | 11.3% | 9.9% | 5.5% | 6.3% | 6.1% | 4.1% | 5.0% | 5.3% | -1.1% | 6.2% | 5.6% | 5.6% | 7.1% | 6.8% | 7.9% | |
| Margins | ||||||||||||||||||||||||||||||
| 53.2% | 58.0% | 58.8% | 61.1% | 55.6% | 57.1% | 57.6% | 58.6% | 56.9% | 56.9% | 56.2% | 55.4% | 54.1% | 53.2% | 52.6% | 59.2% | 60.9% | 59.9% | 60.5% | 60.2% | 60.3% | 63.7% | 62.6% | 62.8% | 60.6% | 63.0% | 61.6% | 59.8% | 59.0% | 51.6% | |
| 30.7% | 22.6% | 24.2% | 28.1% | 30.8% | 34.4% | 38.5% | 39.5% | 57.8% | 33.4% | 37.7% | 37.7% | 37.4% | 36.4% | 35.5% | 31.3% | 36.6% | 36.6% | 39.3% | 39.0% | 41.2% | 45.9% | 44.5% | 37.6% | 32.5% | 38.5% | 37.9% | 33.4% | 33.2% | 29.6% | |
| 22.7% | 17.7% | 17.7% | 18.6% | 19.8% | 22.0% | 26.2% | 76.5% | 38.6% | 27.3% | 28.4% | 27.7% | 25.9% | 24.1% | 23.9% | 19.6% | 24.5% | 28.2% | 27.6% | 29.5% | 30.9% | 20.5% | 44.2% | 31.4% | 25.6% | 30.1% | 31.5% | 33.1% | 33.9% | 29.3% | |
| 13.7% | 15.6% | 17.3% | 28.6% | 27.4% | 27.2% | 29.7% | 29.3% | 102.1% | 22.0% | 36.6% | 25.0% | 26.9% | 26.1% | 22.4% | 29.3% | 32.0% | 29.5% | 34.5% | 33.8% | 28.6% | 37.0% | 39.1% | -9.6% | 45.7% | 42.1% | 38.9% | 43.1% | 35.7% | 37.2% | |
| Returns | ||||||||||||||||||||||||||||||
| 36.1% | 19.0% | 18.8% | 29.1% | 43.5% | 32.6% | 45.6% | 56.8% | 28.3% | 23.0% | 22.6% | 20.4% | 20.7% | 16.5% | 15.9% | 18.2% | 20.0% | 18.8% | 17.6% | 17.0% | 17.5% | 10.9% | 20.8% | 14.6% | 10.5% | 13.8% | 14.4% | 13.0% | 11.8% | 9.5% | |
| 30.4% | 13.7% | 15.3% | 19.7% | 21.1% | 25.2% | 30.6% | 41.8% | 24.8% | 18.1% | 18.5% | 17.2% | 18.6% | 15.0% | 14.6% | 9.7% | 13.2% | 14.1% | 14.0% | 15.0% | 15.8% | 9.2% | 18.6% | 13.4% | 9.7% | 12.8% | 13.3% | 12.3% | 11.3% | 9.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| – | – | – | – | 9.6 | 2.1 | 4.7 | – | – | 4.6 | 4.2 | 2.9 | 2.0 | 1.3 | -2.7 | 15 | 5.5 | -5.3 | -14 | -23 | -26 | -40 | – | -43 | -52 | -61 | -75 | -93 | -83 | – | |
| – | – | – | – | 0.9 | 0.2 | 0.4 | – | – | 0.5 | 0.4 | 0.3 | 0.2 | 0.1 | -0.3 | 1.0 | 0.3 | -0.3 | -0.7 | -1.2 | -1.4 | -1.8 | – | -1.7 | -2.5 | -2.3 | -2.7 | -3.8 | -4.2 | – | |
| 84.4% | 71.7% | 81.3% | 67.7% | 48.6% | 77.2% | 67.2% | 73.5% | 87.6% | 78.9% | 81.7% | 84.3% | 89.7% | 91.0% | 91.6% | 53.4% | 66.3% | 75.1% | 79.6% | 88.0% | 90.4% | 84.2% | 89.2% | 92.1% | 92.0% | 92.7% | 92.2% | 94.7% | 95.8% | 97.3% | |
| – | – | – | – | 0.8 | 0.1 | 0.3 | – | – | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.5 | 0.3 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | |
| Per Share | ||||||||||||||||||||||||||||||
| 0.93 | 0.51 | 0.59 | 0.76 | 0.90 | 1.14 | 1.36 | 4.25 | 2.19 | 1.80 | 2.02 | 1.98 | 1.86 | 1.72 | 1.65 | 2.03 | 2.74 | 3.02 | 3.01 | 3.14 | 3.22 | 2.28 | 4.95 | 3.94 | 2.94 | 4.04 | 4.52 | 4.57 | 3.96 | 3.48 | |
| 4.09 | 2.88 | 3.34 | 4.09 | 4.55 | 5.18 | 5.19 | 5.56 | 5.68 | 6.60 | 7.11 | 7.14 | 7.16 | 7.14 | 6.90 | 10.39 | 11.20 | 10.73 | 10.94 | 10.65 | 10.43 | 11.08 | 11.21 | 12.54 | 11.49 | 13.40 | 14.35 | 13.81 | 11.68 | 11.89 | |
| 2.58 | 2.68 | 3.13 | 2.61 | 2.07 | 3.50 | 2.98 | 7.48 | 7.75 | 7.84 | 8.93 | 9.72 | 8.97 | 10.46 | 10.37 | 11.18 | 13.73 | 16.05 | 17.11 | 18.46 | 18.38 | 20.91 | 23.74 | 27.04 | 28.00 | 29.27 | 31.36 | 35.28 | 33.52 | 36.81 | |
| 0.56 | 0.45 | 0.58 | 1.17 | 1.25 | 1.41 | 1.54 | 1.63 | 5.79 | 1.46 | 2.60 | 1.78 | 1.93 | 1.86 | 1.54 | 3.05 | 3.59 | 3.17 | 3.78 | 3.59 | 2.98 | 4.10 | 4.38 | -1.20 | 5.25 | 5.64 | 5.58 | 5.95 | 4.17 | 4.42 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.